Testing effectiveness (Phase 2)Looking for participantsNCT07374471What this trial is testingMB-001 in Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) Mage Biologics 100
Not applicableLooking for participantsNCT05987852What this trial is testingHyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)Who this might be right forUlcerative Colitis Northwestern University 126
Not applicableLooking for participantsNCT06764706What this trial is testingStudy to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis AbbVie 200
Testing effectiveness (Phase 2)Ended earlyNCT04277546What this trial is testingOpen-label Extension Study of Brazikumab in Ulcerative ColitisWho this might be right forUlcerative Colitis AstraZeneca 57
Large-scale testing (Phase 3)Study completedNCT03283085What this trial is testingA Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)Who this might be right forCrohn's DiseaseUlcerative Colitis Shire 557
Large-scale testing (Phase 3)Study completedNCT02531126What this trial is testingAn Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Celgene 877
Large-scale testing (Phase 3)Ended earlyNCT03758443What this trial is testingEfficacy & Safety of TD-1473 in Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) Theravance Biopharma 239
Large-scale testing (Phase 3)Active Not RecruitingNCT06880744What this trial is testingAssess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to VedolizumabWho this might be right forUlcerative Colitis AbbVie 573
Large-scale testing (Phase 3)Active Not RecruitingNCT04738942What this trial is testingIntravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseWho this might be right forUlcerative ColitisCrohn's Disease Takeda 56
Large-scale testing (Phase 3)Study completedNCT01458951What this trial is testingEvaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Pfizer 547
Testing effectiveness (Phase 2)WithdrawnNCT05121402What this trial is testingSafety and Efficacy Study of TLL018 in the Treatment of Ulcerative ColitisWho this might be right forUlcerative Colitis TLL Pharmaceutical, LLC
Early research (Phase 1)Not Yet RecruitingNCT07744646What this trial is testingAlpha-0261 Tablets for Moderate-to-Severe Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) The First Affiliated Hospital of Anhui Medical University 10
Large-scale testing (Phase 3)Study completedNCT04205643What this trial is testingCT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)Who this might be right forUlcerative Colitis Celltrion 548
Testing effectiveness (Phase 2)Study completedNCT01988961What this trial is testingEvaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forColitis, Ulcerative Janssen Research & Development, LLC 103
Not applicableNot Yet RecruitingNCT07358923What this trial is testingAccuracy of Modified Milan Ultrasound Criteria in Assessing Disease Activity and Severity in Moderate-to-Severe Ulcerative Colitis: a Pilot StudyWho this might be right forUlcerative Colitis (UC) IRCCS San Raffaele 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04033445What this trial is testingGuselkumab in Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Janssen Research & Development, LLC 1,064
Not applicableEnded earlyNCT05069259What this trial is testingGenerate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.Who this might be right forUlcerative Colitis Pfizer 18
Post-approval studies (Phase 4)Ended earlyNCT05369832What this trial is testingAn Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical PracticeWho this might be right forColitis, Ulcerative Bristol-Myers Squibb 139
Testing effectiveness (Phase 2)Study completedNCT06049017What this trial is testingJNJ-77242113 in Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forColitis, Ulcerative Janssen Research & Development, LLC 252
Testing effectiveness (Phase 2)Active Not RecruitingNCT05486104What this trial is testingPhase II Study of Hemay005 in Patients With Active Ulcerative ColitisWho this might be right forModerate to Severe Ulcerative Colitis Ganzhou Hemay Pharmaceutical Co., Ltd 92